Dyskinesia in Patients with Parkinson’s Disease – PPD 88366-01

People with Parkinson’s are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.

You may be eligible to participate in this study if you:
• Are a male or female between age 30-85 years old
• Have Parkinson’s disease, per UK Parkinson’s Disease Society (UKPDS) Brain Bank Clinical Diagnostic Criteria
• Willing and able to comply with all study visits and procedures
• Are on a stable regimen of antiparkinson’s medications for at least 30 days prior to screening

You may NOT participate in this study if you:
• History of seizures within 2 years prior to screening
• History of stroke or transient ischemic attack (TIA) within 2 years prior to screening
• History of cancer within 5 years prior to screening
• Inability to swallow oral tablets
• Hoehn and Yahr Stage V
• Are pregnant or breastfeeding

Contact Information
Mindy Lopez, Study Coordinator
Phone: (212) 241-9038
Email: MINDY.LOPEZ1@MSSM.EDU

Levodopa Induced Dyskinesia

People with Dyskinesia due to their Parkinson’s disease medication are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.

You may be eligible to participate in this study if you:

  • Are a male or female patients between 30 and 85 years of age
  • Have a diagnosis of Parkinson Disease consistent with the UK Parkinson’s Disease Society
  • Have dyskinesia due to the medication taken for Parkinson’s Disease

You may not participate in this study if you:

  • Have a diagnosis of atypical parkinsonism
  • Have a history of severe depression, psychosis or hallucinations within 6 months prior to screening
  • Are pregnant or breastfeeding

Contact Information

Study Coordinator
Christina Rosario
Icahn School of Medicine at Mount Sinai
5 East 98th Street
New York, NY 10029-6574
Telephone: (212) 241-5329
Email: christina.rosario@mssm.edu

 

 

19-02-161 / TX228654